DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Locke FL, Ghobadi A, Jacobson CA. et al.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial.

Lancet Oncol 2019;
20: 31-42

Download Bibliographical Data

Access:
Access: